Clinical Trials Directory

Trials / Completed

CompletedNCT02824679

Effect of Intravenous Hyoscine Butylbromide Injection on First Stage Labour in Primigavidae

Effect of Intravenous Hyoscine Butylbromide Injection on the Course and Duration of First Stage of Labour in Primigavidae

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Ahmed M Maged, MD · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

A case control study conducted on 120 women coming to Cairo University Maternity Hospital .Patients who meet the inclusion criteria were asked to participate in the study and a verbal consent was obtained from each patient. Patients will be divided into three equal groups (A, B, C). A single dose of the drug (placebo or HBB 20mg or HBB 40 mg) will be injected intravenously slowly to groups A, B, C respectively. Labouring mothers will be monitored in bed. Vaginal examination will be conducted every two hours. The duration of the first stage was calculated from the time of cervical dilatation of three to four centimeters in active labour until a fully dilated cervix will be observed

Detailed description

A case control study conducted on 120 women coming to Cairo University Maternity Hospital .Patients who meet the inclusion criteria were asked to participate in the study and a verbal consent was obtained from each patient. Patients will be divided into three equal groups (A, B, C). A single dose of the drug (placebo or HBB 20mg or HBB 40 mg) will be injected intravenously slowly to groups A, B, C respectively. Labouring mothers will be monitored in bed. Vaginal examination will be conducted every two hours. The duration of the first stage was calculated from the time of cervical dilatation of three to four centimeters in active labour until a fully dilated cervix will be observed

Conditions

Interventions

TypeNameDescription
DRUGhyoscine butylbromide20 - 40 mg of hyoscine butylbromide is given intravenously during the first stage of labor
DRUGsaline0.9%normal saline

Timeline

Start date
2015-07-01
Primary completion
2016-12-01
Completion
2017-03-01
First posted
2016-07-07
Last updated
2021-12-14

Source: ClinicalTrials.gov record NCT02824679. Inclusion in this directory is not an endorsement.